Black Americans have double the risk of developing multiple myeloma compared to white Americans and are diagnosed at younger ...

Traditionally carrying a dire prognosis, the treatment paradigm for multiple myeloma is changing, with CAR T therapies, ...

Peripheral blood absolute lymphocyte count at diagnosis is an effective biomarker that can be used to risk-stratify patients with multiple myeloma, according to retrospective study results.Continued ...

Medically reviewed by Marla Anderson, MD Multiple myeloma is a rare blood cancer that develops in the plasma cells, which are ...

A cancer program specialized in treating patients with multiple myeloma developed a participatory care model. Various strategies were used to foster patient participation, including a) partnership ...

The University of Texas at Austin supports cutting-edge research in all disciplines, offering more than 200 dedicated research units and centers. Several research groups report directly to the Vice ...

After hours: January 22 at 4:59:23 PM EST Loading Chart for REG ...